BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15307119)

  • 1. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
    Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of hearing loss among older construction and trade workers at Department of Energy nuclear sites.
    Dement J; Ringen K; Welch L; Bingham E; Quinn P
    Am J Ind Med; 2005 Nov; 48(5):348-58. PubMed ID: 16254949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.
    Cloeren M; Dement J; Gaitens J; Hines S; Diaz L; Tembunde Y; Cranford K; Shorter J; Mosier T; Ringen K;
    Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality of older construction and craft workers employed at Department of Energy (DOE) nuclear sites.
    Dement JM; Ringen K; Welch LS; Bingham E; Quinn P
    Am J Ind Med; 2009 Sep; 52(9):671-82. PubMed ID: 19670258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of respiratory diseases among construction and trade workers at Department of Energy nuclear sites.
    Dement JM; Welch L; Bingham E; Cameron B; Rice C; Quinn P; Ringen K
    Am J Ind Med; 2003 Jun; 43(6):559-73. PubMed ID: 12768606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airways obstruction among older construction and trade workers at Department of Energy nuclear sites.
    Dement JM; Welch L; Ringen K; Bingham E; Quinn P
    Am J Ind Med; 2010 Mar; 53(3):224-40. PubMed ID: 20025074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of a program to prevent beryllium disease.
    Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
    Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic beryllium disease prevention program. Office of Environment, Safety and Health, Department of Energy. Final rule.
    Fed Regist; 1999 Dec; 64(235):68854-914. PubMed ID: 11010683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
    Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
    Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a medical examination program for former workers at a Department of Energy national laboratory.
    Breysse PN; Weaver V; Cadorette M; Wiggs L; Curbow B; Stefaniak A; Melius J; Newman L; Smith H; Schwartz B
    Am J Ind Med; 2002 Nov; 42(5):443-54. PubMed ID: 12382258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2004 Oct; 1(10):648-59. PubMed ID: 15631056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.